Prolactinoma MRI

Prolactinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Prolactinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
ECG
X-ray
Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Prolactinoma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Prolactinoma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Prolactinoma MRI
CDC on Prolactinoma MRI
Prolactinoma MRI in the news
Blogs on Prolactinoma MRI
Directions to Hospitals Treating Prolactinoma
Risk calculators and risk factors for Prolactinoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Magnetic resonance imaging (MRI), is the most sensitive test for detecting pituitary tumors and determining their size. MRI scans may be repeated periodically to assess tumor progression and the effects of therapy. MRI is more sensitive than CT in detecting pituitary tumors.

MRI

Magnetic resonance imaging (MRI), is the most sensitive test for detecting pituitary tumors and determining their size. MRI scans may be repeated periodically to assess tumor progression and the effects of therapy. MRI is more sensitive than CT in detecting pituitary tumors. MRI is the mainstay of imaging for pituitary microadenomas, and required dedicated pituitary sequences (thin slice, small field of view, dynamic contrast acquisition). Contrast enhanced MRIs have a sensitivity of 90%. Post contrast and especially thin section dynamic contrast enhanced imaging is an important part of a pituitary MRI and has significantly improved diagnostic accuracy. Some often subtle morphology changes can be identified on non-contrast images however. These include bulkiness of the gland on the side of the microadenoma, subtle remodelling of the floor of the sella, deviation of the pituitary infundibulum away from the adenoma. Findings on MRI scan suggestive of prolactinoma include:

MRI Component	Features
T1​	usually isointense to normal pituitary
T1 C+ (Gd)	dynamic sequences demonstrate a rounded region of delayed enhancement compared to the rest of the gland delayed images are variable, ranging from hypo-enhancement (most common) to isointense to the rest of the gland, to hyperintense (retained contrast)
T2	variable, but often a little hyperintense

References

Template:WikiDoc Sources